|
Phase 1
|
NCT07439029 |
Mar 2026 → Mar 2027 expected |
Sjogren syndrome, anti-neutrophil cytoplasmic antibody-associated vasculitis, antiphospholipid syndrome, diffuse scleroderma +2 |
Children's Hospital of Fudan University |
Not yet recruiting
|
No outcome recorded
|
|
Phase 1
|
NCT07287930 |
Dec 2025 → Dec 2026 expected |
autoimmune hemolytic anemia |
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology |
Not yet recruiting
|
No outcome recorded
|
|
Phase 1
|
NCT07236801 |
Nov 2025 → Nov 2026 expected |
Sjogren syndrome, anti-neutrophil cytoplasmic antibody-associated vasculitis, antiphospholipid syndrome, myositis disease +2 |
China Immunotech (Beijing) Biotechnology Co., Ltd. |
Recruiting
|
No outcome recorded
|
|
Phase 1
|
NCT07123519 |
Aug 2025 → Aug 2026 overdue |
Sjogren syndrome, anti-neutrophil cytoplasmic antibody-associated vasculitis, antiphospholipid syndrome, lupus nephritis +2 |
China Immunotech (Beijing) Biotechnology Co., Ltd. |
Recruiting
|
No outcome recorded
|
|
Phase 1
|
NCT06770504 |
Jan → Dec 2025 overdue |
autoimmune hemolytic anemia |
Institute of Hematology & Blood Diseases Hospital, China |
Not yet recruiting
|
No outcome recorded
|